Verified Nov 2026
Powertrain & Drivetrain
·

Brentford, England
·
Since 2009
ViiV Healthcare is a British multinational pharmaceutical company established in 2009 as a joint venture between GlaxoSmithKline and Pfizer, with Shionogi joining in 2012. Headquartered in Brentford, England, with 1,000–5,000 employees and revenue exceeding $10 billion, the company specializes in HIV/AIDS medicines and antiretroviral therapies. It serves the medical and industrial-equipment sectors, offering eleven HIV treatments including Triumeq, Dovato, and Cabenuva.
ViiV Healthcare at a glance
Revenue
$10B+
Est. band
Employees
1,000-5,000
Founded
2009
Headquarters
Brentford, England
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
ViiV Healthcare is a British multinational pharmaceutical company established in 2009 as a joint venture between GlaxoSmithKline and Pfizer, with Shionogi joining in 2012. Headquartered in Brentford, England, with 1,000–5,000 employees and revenue exceeding $10 billion, the company specializes in HIV/AIDS medicines and antiretroviral therapies. It serves the medical and industrial-equipment sectors, offering eleven HIV treatments including Triumeq, Dovato, and Cabenuva.
At a glance
Attribute | Detail |
|---|---|
Founded | 2009 |
Headquarters | Brentford, England |
Employees | 1,000-5,000 |
Revenue | $10B+ (estimated) |
Primary capability | Powertrain & Drivetrain |
What ViiV Healthcare makes
The company develops antiretroviral therapies, prevention options, and pre-exposure prophylaxis (PrEP) solutions for HIV treatment and prevention.
Products and capabilities described on the company's own site include LED (source: viivhealthcare.com).
Latest developments
2026-11-10 — [Press release] ViiV Healthcare at HIV Glasgow 2026 (eatg.org)
2026-11-05 — ViiV Healthcare Commits $100 Million to Build More Resilient Local HIV Care Networks Across the United States (viivhealthcare.com)
2026-10-21 — ViiV Healthcare Announces CEO Transition (viivhealthcare.com)
2026-10-12 — ViiV Healthcare and Axmed partner to expand access to HIV medicines in middle-income countries (viivhealthcare.com)
2026-09-15 — Empowering Communities: ViiV Healthcare Awards $33 Million in U.S. Grants to Advance HIV Response in the US (viivhealthcare.com)
2026-01-20 — GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding (viivhealthcare.com)
Company details
ViiV Healthcare is jointly owned by GlaxoSmithKline, Pfizer, and Shionogi, with significant operations in the UK and the US, particularly in Raleigh, North Carolina. ViiV Healthcare was founded in 2009, has an estimated 1,000-5,000 employees, and is headquartered in Brentford, England.
Frequently asked questions
What does ViiV Healthcare make?
ViiV Healthcare is a British multinational pharmaceutical company established in 2009 as a joint venture between GlaxoSmithKline and Pfizer, with Shionogi joining in 2012. Headquartered in Brentford, England, with 1,000–5,000 employees and revenue exceeding $10 billion, the company specializes in HIV/AIDS medicines and antiretroviral therapies. It serves the medical and industrial-equipment sectors, offering eleven HIV treatments including Triumeq, Dovato, and Cabenuva.
Where is ViiV Healthcare headquartered?
ViiV Healthcare is headquartered in Brentford, England (995 Great West Road, Brentford, England, TW8 9).
When was ViiV Healthcare founded?
ViiV Healthcare was founded in 2009.
How big is ViiV Healthcare?
ViiV Healthcare has an estimated 1,000-5,000 employees, with revenue in the $10B+ range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
